1609261-17-7

Upstream product

• 100-44-7 benzyl chloride 
• 27065-65-2 methyl 4-benzyloxy-3,5-dimethoxybenzoate 
• 1001354-10-4 (2S,4R)-4-methoxypyrrolidine-2-carboxylic acid hydrochloride 
• 14588-60-4 4-(benzyloxy)-3,5-dimethoxybenzoic acid 
• 83624-01-5 (2S,4R)-1-(tert-butoxycarbonyl)-4-methoxypyrrolidine-2-carboxylic acid 
• 884-35-5 methyl syringate 

Downstream Products

• 1609261-26-8 (S)-1-((2S,4R)-1-(4-(benzyloxy)-3,5-dimethoxybenzoyl)-4-methoxypyrrolidine-2-carbonyl)pyrrolidine-2-carbonitrile 

Relevant academic research and scientific papers

1-[1-(BENZOYL)-PYRROLIDINE-2-CARBONYL]-PYRROLIDINE-2-CARBONITRILE DERIVATIVES

The present invention relates to 1-[1-(benzoyl)-pyrrolidine-2-carbonyl]-pyrrolidine-2-carbonitrile derivatives having pharmacological activity formula (I) to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use in therapy and/or prophylaxis of a cognitive disorder.

1-[1-(benzoyl)-pyrrolidine-2-carbonyl]-pyrrolidine-2-carbonitrile derivatives

The present invention relates to 1-[1-(benzoyl)-pyrrolidine-2-carbonyl]-pyrrolidine-2-carbonitrile derivatives having pharmacological activity to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use in therapy and/or prophylaxis of a cognitive disorder.